{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:53:32Z","timestamp":1787698412645,"version":"build-2784847793"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Are the reproductive outcomes (clinical, obstetric and perinatal) different between follicular phase stimulation (FPS)- and luteal phase stimulation (LPS)-derived euploid blastocysts?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>No difference was observed between FPS- and LPS-derived euploid blastocysts after vitrified-warmed single embryo transfer (SET).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Technical improvements in IVF allow the implementation non-conventional controlled ovarian stimulation (COS) protocols for oncologic and poor prognosis patients. One of these protocols begins LPS 5 days after FPS is ended (DuoStim). Although, several studies have reported similar embryological outcomes (e.g. fertilization, blastulation, euploidy) between FPS- and LPS-derived cohort of oocytes, information on the reproductive (clinical, obstetric and perinatal) outcomes of LPS-derived blastocysts is limited to small and retrospective studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>Multicenter study conducted between October 2015 and March 2019 including all vitrified-warmed euploid single blastocyst transfers after DuoStim. Only first transfers of good quality blastocysts (\u2265BB according to Gardner and Schoolcraft\u2019s classification) were included. If euploid blastocysts obtained after both FPS and LPS were available the embryo to transfer was chosen blindly. The primary outcome was the live birth rate (LBR) per vitrified-warmed single euploid blastocyst transfer in the two groups. To achieve 80% power (\u03b1\u2009=\u20090.05) to rule-out a 15% difference in the LBR, a total of 366 first transfers were required. Every other clinical, as well as obstetric and perinatal outcomes, were recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Throughout the study period, 827 patients concluded a DuoStim cycle and among them, 339 did not identify any transferable blastocyst, 145 had an euploid blastocyst after FPS, 186 after LPS and 157 after both FPS and LPS. Fifty transfers of poor quality euploid blastocysts were excluded and 49 patients did not undergo an embryo transfer during the study period. Thus, 389 patients had a vitrified-warmed SET of a good quality euploid blastocyst (182 after FPS and 207 after LPS). For 126 cases (32%) where both FPS- and LPS-derived good quality blastocysts were available, the embryo transferred was chosen blindly with a \u2018True Random Number Generator\u2019 function where \u20180\u2019 stood for FPS-derived euploid blastocysts and \u20181\u2019 for LPS-derived ones (n\u2009=\u200970 and 56, respectively) on the website random.org. All embryos were obtained with the same ovarian stimulation protocol in FPS and LPS (GnRH antagonist protocol with fixed dose of rec-FSH plus rec-LH and GnRH-agonist trigger), culture conditions (continuous culture in a humidified atmosphere with 37\u00b0C, 6% CO2 and 5% O2) and laboratory protocols (ICSI, trophectoderm biopsy in Day 5\u20137 without assisted hatching in Day 3, vitrification and comprehensive chromosome testing). The women whose embryos were included had similar age (FPS: 38.5\u2009\u00b1\u20093.1 and LPS: 38.5\u2009\u00b1\u20093.2 years), prevalence of male factor, antral follicle count, basal hormonal characteristics, main cause of infertility and previous reproductive history (i.e. previous live births, miscarriages and implantation failures) whether the embryo came from FPS or LPS. All transfers were conducted after warming in an artificial cycle. The blastocysts transferred after FPS and LPS were similar in terms of day of full-development and morphological quality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>The positive pregnancy test rates for FPS- and LPS-derived euploid blastocysts were 57% and 62%, biochemical pregnancy loss rates were 10% and 8%, miscarriage rates were 15% and 14% and LBRs were 44% (n\u2009=\u200980\/182, 95% CI 37\u201351%) and 49% (n\u2009=\u2009102\/207, 95% CI 42\u201356%; P\u2009=\u20090.3), respectively. The overall odds ratio for live birth (LPS vs FPS (reference)) adjusted for day of blastocyst development and quality, was 1.3, 95% CI 0.8\u20132.0, P\u2009=\u20090.2. Among patients with euploid blastocysts obtained following both FPS and LPS, the LBRs were also similar (53% (n\u2009=\u200937\/70, 95% CI 41\u201365%) and 48% (n\u2009=\u200927\/56, 95% CI 35\u201362%) respectively; P\u2009=\u20090.7). Gestational issues were experienced by 7.5% of pregnant women after FPS- and 10% of women following LPS-derived euploid single blastocyst transfer. Perinatal issues were reported in 5% and 0% of the FPS- and LPS-derived newborns, respectively. The gestational weeks and birthweight were similar in the two groups. A 5% pre-term delivery rate was reported in both groups. A low birthweight was registered in 2.5% and 5% of the newborns, while 4% and 7% showed high birthweight, in FPS- and LPS-derived euploid blastocyst, respectively. Encompassing the 81 FPS-derived newborns, a total of 9% were small and 11% large for gestational age. Among the 102 LPS-derived newborns, 8% were small and 6% large for gestational age. No significant difference was reported for all these comparisons.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The LPS-derived blastocysts were all obtained after FPS in a DuoStim protocol. Therefore, studies are required with LPS-only, late-FPS and random start approaches. The study is powered to assess differences in the LBR per embryo transfer, therefore obstetric and perinatal outcomes should be considered observational. Although prospective, the study was not registered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>This study represents a further backing of the safety of non-conventional COS protocols. Therefore, LPS after FPS (DuoStim protocol) is confirmed a feasible and efficient approach also from clinical, obstetric and perinatal perspectives, targeted at patients who need to reach the transfer of an euploid blastocyst in the shortest timeframe possible due to reasons such as cancer, advanced maternal age and\/or reduced ovarian reserve and poor ovarian response.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>None.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deaa203","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:28:55Z","timestamp":1595590135000},"page":"2598-2608","source":"Crossref","is-referenced-by-count":53,"title":["The euploid blastocysts obtained after luteal phase stimulation show the same clinical, obstetric and perinatal outcomes as follicular phase stimulation-derived ones: a multicenter study"],"prefix":"10.1093","volume":"35","author":[{"given":"Alberto","family":"Vaiarelli","sequence":"first","affiliation":[{"name":"Clinica Valle Giulia, GENERA Center for Reproductive Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Cimadomo","sequence":"additional","affiliation":[{"name":"Clinica Valle Giulia, GENERA Center for Reproductive Medicine, Rome, Italy"},{"name":"Clinica Ruesch, GENERA Center for Reproductive Medicine, Napoli, Italy"},{"name":"GENERA Veneto, GENERA Center for Reproductive Medicine, Marostica, Italy"},{"name":"GENERA Umbria, GENERA Center for Reproductive Medicine, Umbertide, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminia","family":"Alviggi","sequence":"additional","affiliation":[{"name":"Clinica Ruesch, GENERA Center for Reproductive Medicine, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sansone","sequence":"additional","affiliation":[{"name":"Clinica Ruesch, GENERA Center for Reproductive Medicine, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Trabucco","sequence":"additional","affiliation":[{"name":"Clinica Ruesch, GENERA Center for Reproductive Medicine, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Dusi","sequence":"additional","affiliation":[{"name":"GENERA Veneto, GENERA Center for Reproductive Medicine, Marostica, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Buffo","sequence":"additional","affiliation":[{"name":"GENERA Veneto, GENERA Center for Reproductive Medicine, Marostica, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Barnocchi","sequence":"additional","affiliation":[{"name":"GENERA Umbria, GENERA Center for Reproductive Medicine, Umbertide, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Fiorini","sequence":"additional","affiliation":[{"name":"GENERA Umbria, GENERA Center for Reproductive Medicine, Umbertide, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Colamaria","sequence":"additional","affiliation":[{"name":"Clinica Valle Giulia, GENERA Center for Reproductive Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Giuliani","sequence":"additional","affiliation":[{"name":"Clinica Valle Giulia, GENERA Center for Reproductive Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Argento","sequence":"additional","affiliation":[{"name":"Clinica Valle Giulia, GENERA Center for Reproductive Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rienzi","sequence":"additional","affiliation":[{"name":"Clinica Valle Giulia, GENERA Center for Reproductive Medicine, Rome, Italy"},{"name":"Clinica Ruesch, GENERA Center for Reproductive Medicine, Napoli, Italy"},{"name":"GENERA Veneto, GENERA Center for Reproductive Medicine, Marostica, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Ubaldi","sequence":"additional","affiliation":[{"name":"Clinica Valle Giulia, GENERA Center for Reproductive Medicine, Rome, Italy"},{"name":"Clinica Ruesch, GENERA Center for Reproductive Medicine, Napoli, Italy"},{"name":"GENERA Veneto, GENERA Center for Reproductive Medicine, Marostica, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,20]]},"reference":[{"key":"2020111005433569000_deaa203-B1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/humupd\/dmr039","article-title":"Ovarian antral folliculogenesis during the human menstrual cycle: a review","volume":"18","author":"Baerwald","year":"2012","journal-title":"Hum Reprod Update"},{"key":"2020111005433569000_deaa203-B2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10815-016-0721-5","article-title":"Ovarian stimulation in the luteal phase: systematic review and meta-analysis","volume":"33","author":"Boots","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2020111005433569000_deaa203-B3","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2020111005433569000_deaa203-B4","doi-asserted-by":"crossref","first-page":"e100011","DOI":"10.1371\/journal.pone.0100011","article-title":"Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study","volume":"9","author":"Bu","year":"2014","journal-title":"PLoS One"},{"key":"2020111005433569000_deaa203-B5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/humrep\/deu033","article-title":"Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts","volume":"29","author":"Capalbo","year":"2014","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.fertnstert.2015.02.020","article-title":"Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles","volume":"103","author":"Chen","year":"2015","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B7","doi-asserted-by":"crossref","first-page":"e0140779","DOI":"10.1371\/journal.pone.0140779","article-title":"Can comprehensive chromosome screening technology improve IVF\/ICSI outcomes? A meta-analysis","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"2020111005433569000_deaa203-B8","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/humrep\/dey291","article-title":"Associations of blastocyst features, trophectoderm biopsy and other laboratory practice with post-warming behavior and implantation","volume":"33","author":"Cimadomo","year":"2018","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10815-019-01607-6","article-title":"Similar miRNomic signatures characterize the follicular fluids collected after follicular and luteal phase stimulations in the same ovarian cycle","volume":"37","author":"Cimadomo","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2020111005433569000_deaa203-B10","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/humrep\/dez078","article-title":"Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing","volume":"34","author":"Cimadomo","year":"2019","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B11","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/humrep\/dey217","article-title":"Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle","volume":"33","author":"Cimadomo","year":"2018","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.fertnstert.2015.08.038","article-title":"Comprehensive chromosome screening improves embryo selection: a meta-analysis","volume":"104","author":"Dahdouh","year":"2015","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/humupd\/dmu027","article-title":"Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence","volume":"20","author":"Evans","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2020111005433569000_deaa203-B14","first-page":"378","volume-title":"Towards Reproductive Certainty: Fertility and Genetics Beyond","author":"Gardner","year":"1999"},{"key":"2020111005433569000_deaa203-B15","first-page":"2282","article-title":"Perinatal and maternal outcome after vitrification of blastocysts: a Nordic study in singletons from the CoNARTaS group","volume":"34","author":"Ginstrom Ernstad","year":"2019","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/humupd\/dmy006","article-title":"Determinants of monozygotic twinning in ART: a systematic review and a meta-analysis","volume":"24","author":"Hviid","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2020111005433569000_deaa203-B17","doi-asserted-by":"crossref","first-page":"S619","DOI":"10.1016\/j.ajog.2017.12.010","article-title":"The World Health Organization fetal growth charts: concept, findings, interpretation, and application","volume":"218","author":"Kiserud","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2020111005433569000_deaa203-B18","doi-asserted-by":"crossref","first-page":"e1002220","DOI":"10.1371\/journal.pmed.1002220","article-title":"The World Health Organization fetal growth charts: a multinational longitudinal study of ultrasound biometric measurements and estimated fetal weight","volume":"14","author":"Kiserud","year":"2017","journal-title":"PLoS Med"},{"key":"2020111005433569000_deaa203-B19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10815-016-0671-y","article-title":"Erratum to: Serum progesterone levels greater than 20 ng\/ml on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates","volume":"33","author":"Kofinas","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2020111005433569000_deaa203-B20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00404-011-2045-0","article-title":"Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality","volume":"285","author":"Lahoud","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"2020111005433569000_deaa203-B23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09513590.2016.1266325","article-title":"Individual luteolysis post GnRH-agonist-trigger in GnRH-antagonist protocols","volume":"33","author":"Lawrenz","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2020111005433569000_deaa203-B24","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.theriogenology.2011.06.012","article-title":"Influence of progesterone on oocyte quality and embryo development in cows","volume":"76","author":"Lonergan","year":"2011","journal-title":"Theriogenology"},{"key":"2020111005433569000_deaa203-B25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/humrep\/dez234","article-title":"The effect of ICSI-related procedural timings and operators on the outcome","volume":"35","author":"Maggiulli","year":"2020","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/humupd\/dmx031","article-title":"Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?","volume":"24","author":"Maheshwari","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2020111005433569000_deaa203-B27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.fertnstert.2010.06.064","article-title":"Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation","volume":"95","author":"Maman","year":"2011","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B28","first-page":"211","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2020111005433569000_deaa203-B29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humupd\/dmz037","article-title":"Ovarian stimulation for freeze-all IVF cycles: a systematic review","volume":"26","author":"Mizrachi","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2020111005433569000_deaa203-B30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.rbmo.2014.08.010","article-title":"Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technology is limited","volume":"29","author":"Moffat","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2020111005433569000_deaa203-B31","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.fertnstert.2011.04.079","article-title":"Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation","volume":"96","author":"Nayak","year":"2011","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.rbmo.2017.06.002","article-title":"Random-start ovarian stimulation in women desiring elective cryopreservation of oocytes","volume":"35","author":"Pereira","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2020111005433569000_deaa203-B33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-0032-1311525","article-title":"To transfer fresh or thawed embryos?","volume":"30","author":"Pinborg","year":"2012","journal-title":"Semin Reprod Med"},{"key":"2020111005433569000_deaa203-B34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.fertnstert.2016.04.006","article-title":"Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection","volume":"106","author":"Qin","year":"2016","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/humrep\/dez238","article-title":"Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality","volume":"35","author":"Racca","year":"2020","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/humrep\/dey031","article-title":"Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality?","volume":"33","author":"Racca","year":"2018","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1477-7827-12-69","article-title":"High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study","volume":"12","author":"Requena","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"2020111005433569000_deaa203-B38","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/det306","article-title":"Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis","volume":"28","author":"Reynolds","year":"2013","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B39","first-page":"139","article-title":"Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance","volume":"23","author":"Rienzi","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2020111005433569000_deaa203-B40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10815-019-01638-z","article-title":"What is the true place of a double stimulation and double oocyte retrieval in the same cycle for patients diagnosed with poor ovarian reserve? A systematic review including a meta-analytical approach","volume":"37","author":"Sfakianoudis","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2020111005433569000_deaa203-B41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rbmo.2018.07.006","article-title":"New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation","volume":"37","author":"Sighinolfi","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2020111005433569000_deaa203-B42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0015-0282(98)00404-X","article-title":"Administration of progesterone before oocyte retrieval negatively affects the implantation rate","volume":"71","author":"Sohn","year":"1999","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.fertnstert.2012.01.115","article-title":"Development and validation of an accurate quantitative real-time polymerase chain reaction-based assay for human blastocyst comprehensive chromosomal aneuploidy screening","volume":"97","author":"Treff","year":"2012","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/14647273.2017.1287433","article-title":"Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients","volume":"20","author":"Tsampras","year":"2017","journal-title":"Hum Fertil (Camb)"},{"key":"2020111005433569000_deaa203-B45","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.fertnstert.2016.03.002","article-title":"Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation","volume":"105","author":"Ubaldi","year":"2016","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.23736\/S0026-4784.19.04390-9","article-title":"Double stimulation in the same ovarian cycle (DuoStim) is an intriguing strategy to improve oocyte yield and the number of competent embryos in a short timeframe","volume":"71","author":"Vaiarelli","year":"2019","journal-title":"Minerva Ginecol"},{"key":"2020111005433569000_deaa203-B47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.fertnstert.2019.09.012","article-title":"Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series","volume":"113","author":"Vaiarelli","year":"2020","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.rbmo.2018.05.019","article-title":"Biochemical pregnancy loss after frozen embryo transfer seems independent of embryo developmental stage and chromosomal status","volume":"37","author":"Vaiarelli","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2020111005433569000_deaa203-B49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/03009734.2020.1734694","article-title":"DuoStim\u2014a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review","volume":"125","author":"Vaiarelli","year":"2020","journal-title":"Ups J Med Sci"},{"key":"2020111005433569000_deaa203-B50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fendo.2018.00317","article-title":"Double stimulation in the same ovarian cycle (DuoStim) to maximize the number of oocytes retrieved from poor prognosis patients: a multicenter experience and SWOT analysis","volume":"9","author":"Vaiarelli","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2020111005433569000_deaa203-B51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/GCO.0000000000000365","article-title":"Dual ovarian stimulation and random start in assisted reproductive technologies: from ovarian biology to clinical application","volume":"29","author":"Vaiarelli","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2020111005433569000_deaa203-B52","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.fertnstert.2015.12.022","article-title":"Distribution patterns of segmental aneuploidies in human blastocysts identified by next-generation sequencing","volume":"105","author":"Vera-Rodriguez","year":"2016","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B53","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.fertnstert.2008.08.011","article-title":"Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase","volume":"92","author":"von Wolff","year":"2009","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B54","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/cen.12983","article-title":"Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study","volume":"84","author":"Wang","year":"2016","journal-title":"Clin Endocrinol (Oxf"},{"key":"2020111005433569000_deaa203-B55","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(18)32843-5","article-title":"Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial","volume":"393","author":"Wei","year":"2019","journal-title":"Lancet"},{"key":"2020111005433569000_deaa203-B56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B57","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The international glossary on infertility and fertility care, 2017","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum Reprod"},{"key":"2020111005433569000_deaa203-B58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"2020111005433569000_deaa203-B59","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fendo.2019.00448","article-title":"Evaluation of ovarian stimulation initiated from the late follicular phase using human menopausal gonadotropin alone in normal-ovulatory women for treatment of infertility: a retrospective cohort study","volume":"10","author":"Zhu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/11\/2598\/34221729\/deaa203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/11\/2598\/34221729\/deaa203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T10:45:05Z","timestamp":1605005105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/11\/2598\/5909135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,20]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,9,20]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa203","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,9,20]]}}}